Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term follow-up after purine analogue therapy in hairy cell leukaemia.

Best practice & research. Clinical haematology - 1 Dec 2015

Else Monica, Dearden Claire E, Catovsky Daniel

Abstract excerpt

Since 2006 when we last reviewed the literature concerning the use of purine analogues in hairy cell leukaemia (HCL), results from several new and updated series have been published. Here we examine these reports and consider their implications for patient management. The two purine analogues pentostatin and cladribine remain the first-line treatments of choice for all patients with HCL. Although they have not...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B-Lymphocytes
Share to Indoles
Share to Leukemia, Hairy Cell

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Recurrence

Share to Remission Induction

Share to Rituximab

Share to Sulfonamides

Share to Vemurafenib

Source

Open in PubMed Open full text

Identifiers

PMID: 26614900
DOI: 10.1016/j.beha.2015.09.004
PMCID: PMC5509559

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term follow-up after purine analogue therapy in hairy cell leukaemia.PMID 26614900Read ↗

Hairy cell leukemia: update and current therapeutic approach.Semantic proximity Read ↗

Historical overview of hairy cell leukemia.Semantic proximity Read ↗

Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up.Semantic proximity Read ↗

Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia.Semantic proximity Read ↗

Biology and Treatment of Hairy Cell Leukemia.Semantic proximity Read ↗

Update on the biology and treatment options for hairy cell leukemia.Semantic proximity Read ↗

Chemoimmunotherapy for hairy cell leukemia.Semantic proximity Read ↗

New insights in the management of patients with hairy cell leukemia.Semantic proximity Read ↗

How I manage patients with hairy cell leukaemia.Semantic proximity Read ↗

[Hairy cell leukemia: What are the best treatment options for relapsed or refractory patients?]Semantic proximity Read ↗

[Novelties in the diagnostics and therapy of hairy cell leukemia].Semantic proximity Read ↗

Treatment of refractory hairy cell leukemia with a BRAF-inhibitor: lessons to be learnt.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.